眼部保健品市場：依成分、適應症、劑型、銷售管道及地區分類。

預計到2026年，眼保健品市場規模將達到35.144億美元，到2033年將達到59.842億美元。預計從2026年到2033年，該市場將以7.9%的複合年成長率成長。

隨著螢幕使用時間和電子設備使用量的增加，人們對眼部健康的關注日益成長。常見的眼睛問題包括眼睛疲勞、眼睛乾澀、眼睛發紅、眼睛刺激和流淚。此外，常見的眼科疾病包括老齡化黃斑部病變（AMD）、白內障和青光眼。老齡化黃斑部病變是眼科疾病。雖然這種疾病不會導致失明，但會造成嚴重的視力障礙。眼睛問題的主要症狀包括視力下降和色覺減退。

白內障是由於眼球晶狀體變得渾濁引起的。眼內蛋白質分解，導致視力模糊、視物變色和其他視覺障礙。白內障的主要症狀包括視力模糊、複視和夜視能力下降。青光眼是眼科疾病。青光眼與眼內壓力升高有關。眼內壓力升高會損害視神經。在嚴重的情況下，青光眼會導致永久性視力喪失。青光眼的主要症狀包括眼睛發紅、眼痛和視物周圍出現光暈。醫生會開立含有葉黃素、玉米黃素、 Omega-3脂肪酸、維生素A、BETA-胡蘿蔔素和越橘萃取物等成分的藥物來治療白內障和青光眼等眼科疾病。

市場動態

預計在預測期內，新產品的監管核准將推動全球眼保健品市場的成長。例如，2023年3月7日，致力於眼部護理產品研發的生物製藥公司NovaBay Pharmaceuticals, Inc.推出了“Avenova Eye Health Support”，這是一款富含抗氧化劑的新型口服補充劑，能夠舒緩眼睛乾澀，促進整體眼部健康。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球眼部保健品市場的主要參與者進行了分析：公司概況、財務績效、產品系列、企業發展區域、分銷策略、關鍵發展和策略。
• 本調查涵蓋的主要公司包括輝瑞公司、博士倫健康公司、愛爾康實驗室公司、Alliance Pharma PLC、Allied Biotech Corporation、BASF、安麗公司、Butterflies Healthcare Ltd、康寶萊營養有限公司、SUSS Technology Corp.、Eyescience Labs、Nordic Naturals、Vitabiotics Ltd. 和 Akorn Incorporated。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、政府舉措、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球眼部保健品市場報告的目標相關人員廣泛，包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 近期產品發布
• 流行病學
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析

第4章：全球眼部保健品市場：依成分類型分類，2021-2033年

• 葉黃素和玉米黃質
• Omega-3脂肪酸
• 維生素A
• BETA-胡蘿蔔素
• 越橘萃取物
• 其他

第5章 全球眼部保健品市場：依適應症類型分類，2021-2033年

• 老齡化黃斑部病變（AMD）
• 白內障
• 乾眼症
• 青光眼
• 其他

第6章 全球眼部保健品市場：依劑型分類，2021-2033年

• 藥片
• 膠囊
• 軟凝膠
• 其他

第7章 全球眼保健品市場：依通路分類，2021-2033年

• 醫院藥房
• 零售藥房
• 網路藥房

第8章：全球眼部保健品市場：依地區分類，2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• Pfizer Inc
• Bausch Health Companies Inc
• Alcon
• Alliance Pharma PLC
• Allied Biotech Corporation
• BASF SE
• Amway India Enterprises Pvt. Ltd
• Butterflies Healthcare Ltd
• Herbalife International, Inc
• Nordic Naturals
• Vitabiotics Ltd
• Akorn Operating Company LLC

第10章

• 調查方法
• 關於本公司

Eye Health Supplements Market is estimated to be valued at USD 3,514.4 Mn in 2026 and is expected to reach USD 5,984.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.

Eye health is a growing concern owing to increased screen time and digital exposure. Common eye problems include eye strain, dry and red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include Age-related Macular Degeneration (AMD), cataract, and glaucoma. Age-related macular degeneration is an eye disease that gets severe over time. The disease does not cause blindness but can cause severe vision-related problems. Some of the major symptoms of eye problems are less clear vision and worse colour perception.

Cataract occurs when the natural lens of eyes become cloudy. Proteins present in the eyes break down and this causes things to look blurry, hazy, or less colourful. Some of the major symptoms of cataract are blurry vision, seeing double objects, and having trouble seeing at night. Glaucoma is an eye disease that damages eye's optic nerve. Glaucoma is related to the build up of pressure inside the eyes. The increased pressure can cause damage to the optic nerve. If the damage is severe glaucoma can cause permanent vision loss. Some of the major symptoms of glaucoma are redness in eyes, eye pain, and seeing halos around light. Doctors prescribe medicines for eye related diseases, such as cataract, glaucoma, and others, which include ingredients such as lutein and zeaxanthin, omega-3 fatty acids, vitamin A, beta-carotene, and bilberry extracts.

Market Dynamics

Approval of new products by regulatory bodies is expected to propel the global eye health supplement market growth during the forecast period. For instance, on March 7, 2023, NovaBay Pharmaceuticals, Inc, a biopharmaceutical company that develops products for the eye care market, launched Avenova Eye Health Support, a new antioxidant-rich oral supplement to comfort dry eyes and promote the overall eye health.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global eye health supplement market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• The key players covered as a part of this study include: Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC, Allied Biotech Corporation, BASF SE, Amway Corp., Butterflies Healthcare Ltd, Herballife Nutrition Ltd., SUSS Technology Corp., Eyescience Labs, Nordic Naturals, Vitabiotics Ltd., and Akorn Incorporated
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global eye health supplement market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for the global eye health supplements market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• Global Eye Health Supplements Market, By Ingredients Type (Revenue, USD Mn, 2021 - 2033)
• Lutein And Zexanthin
• Omega- 3 Fatty Acids
• Vitamin A
• Beta Carotene
• Bilberry Extracts
• Others
• Global Eye Health Supplements Market, By Indication Type (Revenue, USD Mn, 2021 - 2033)
• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Glaucoma
• Others
• Global Eye Health Supplements Market, By Dosage Type (Revenue, USD Mn, 2021 - 2033)
• Tablets
• Capsules
• Soft Gels
• Others
• Global Eye Health Supplements Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Eye Health Supplements Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Pfizer Inc
• Bausch Health Companies Inc
• Alcon
• Alliance Pharma PLC
• Allied Biotech Corporation
• BASF SE
• Amway India Enterprises Pvt. Ltd
• Butterflies Healthcare Ltd
• Herbalife International, Inc
• Nordic Naturals
• Vitabiotics Ltd
• Akorn Operating Company LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Ingredients Type
  • Market Snapshot, By Indication Type
  • Market Snapshot, By Dosage Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Eye Health Supplements Market, By Ingredients Type, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Lutein and Zeaxanthin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Omega-3 Fatty Acids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Vitamin A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Beta - Carotene
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Bilberry Extracts
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Eye Health Supplements Market, By Indication Type, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Age-related Macular Degeneration (AMD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Cataract
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Dry Eye Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Glaucoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Eye Health Supplements Market, By Dosage Type, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Capsules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Soft Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Eye Health Supplements Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

8. Global Eye Health Supplements Market, By Region, 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Ingredients type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel Type, 2021 - 2033, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bausch Health Companies Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alcon
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alliance Pharma PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Allied Biotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BASF SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amway India Enterprises Pvt. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Butterflies Healthcare Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Herbalife International, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nordic Naturals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vitabiotics Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Akorn Operating Company LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us